Delivery Order SPE2DB20D3103-SPE2DB22FL3V1
- Not listed
- This federal contract award, with a ceiling value of $3,461.05, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract provides for the delivery of Fluorouracil 0.5% Cream, a topical medication used in the treatment of certain types of skin cancer. The award is a Delivery Order issued under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,549.72 firm-fixed-price delivery order covers the supply of Fluorouracil 0.5% Cream, a specialty medication used for various medical conditions. The award is a task order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Fluorouracil 0.5% cream in 30 gram quantities. The $2,352.07 firm fixed-price delivery order was made under a broader Indefinite Delivery Contract (IDC) with Cencora, Inc. (doing business as Amerisourcebergen) valued at up to $999,999,999.00 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen...
- This federal contract award, valued at $1,211.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fluorouracil 5% Cream, a prescription medication, with a performance period through May 4, 2023. The award is not designated as a set-aside and was issued as a delivery order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $1,761.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award covers the delivery of 4568223554 - FLUOROURACIL 5% CREAM 40GM, with a period of performance extending through May 14, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
- This federal contract award, valued at $2,336.28, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of FLUOROURACIL 5% CREAM 40GM, a medical product used for various healthcare applications. The contract has an ultimate completion date of November 18, 2024 and is structured as a Firm Fixed Price Delivery Order, without any set-aside designation. AmerisourceBergen holds a significant Indefinite...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,951.80 firm fixed-price delivery order is for the supply of FLUOROURACIL 5% CREAM 40GM, a pharmaceutical product. The contract has an ultimate completion date of February 24, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,729.52 Firm Fixed Price Delivery Order is for the supply of 4558909963 - Fluorouracil 5% Cream, 40GM. The contract has an ultimate completion date of October 28, 2022 and was awarded on October 27, 2022. This award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite...
- The federal contract award SPE2DB20D3103|SPE2DB23FM7U5 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4560272435 - Fluorouracil 5% Cream 40GM. The $1,385.83 firm fixed price delivery order has a completion date of March 16, 2023 and was awarded on March 15, 2023. The contract is not designated with a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,274.86 firm fixed-price contract is for the delivery of 4555497530 - Fluorouracil 0.5% Cream 30GM, a pharmaceutical product. The contract has a completion date of November 23, 2021 and was awarded on November 22, 2021. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB22FL3V1Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,280.92 firm fixed-price delivery order is for the supply of Fluorouracil 5% topical solution, a medication used for the treatment of certain skin conditions. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This $999,999,999 IDC serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 10/18/21 |